Accounts Receivable are created when a customer has received a product but has not yet paid for that product. US Stem Cell's accounts receivables for the quarter that ended in Dec. 2022 was $0.00 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
US Stem Cell's Days Sales Outstanding for the quarter that ended in Dec. 2022 was 18.25.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. US Stem Cell's Net-Net Working Capital per share for the quarter that ended in Dec. 2022 was $-0.02.
US Stem Cell Accounts Receivable Historical Data
The historical data trend for US Stem Cell's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.
US Stem Cell Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
US Stem Cell's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), US Stem Cell's accounts receivable are only considered to be worth 75% of book value:
US Stem Cell's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
US Stem Cell Accounts Receivable Related Terms
Thank you for viewing the detailed overview of US Stem Cell's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.
US Stem Cell Inc is a biotechnology company engaged in the discovery and development of autologous cell therapies for the treatment of chronic and acute heart damage. Its product includes MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
USRM has been successfully added to your 